These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10905752)

  • 21. [Hospital drug safety: medication errors and adverse drug reactions].
    Krähenbühl-Melcher A; Krähenbühl S
    Praxis (Bern 1994); 2005 Jun; 94(24-25):1031-8. PubMed ID: 15997721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
    Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML
    Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
    Krähenbühl S
    Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-related problems in hospitals: a review of the recent literature.
    Krähenbühl-Melcher A; Schlienger R; Lampert M; Haschke M; Drewe J; Krähenbühl S
    Drug Saf; 2007; 30(5):379-407. PubMed ID: 17472418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some observations on pharmacoepidemiology in Europe.
    van Boxtel CJ; Wang G
    Neth J Med; 1997 Dec; 51(6):205-12. PubMed ID: 9499691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interest of pharmacoepidemiology in pharmacovigilance: Post-authorization safety studies in regulatory pharmacovigilance activity.
    Abou Taam M; Ferard C; Rocle P; Maison P
    Therapie; 2019 Apr; 74(2):301-306. PubMed ID: 30704766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance.
    Pinheiro L; Blake K; Januskiene J; Yue QY; Arlett P
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):705-12. PubMed ID: 27004571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.
    Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A
    BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients.
    Vermeulen KM; van Doormaal JE; Zaal RJ; Mol PG; Lenderink AW; Haaijer-Ruskamp FM; Kosterink JG; van den Bemt PM
    Int J Med Inform; 2014 Aug; 83(8):572-80. PubMed ID: 24929633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospital.
    Shen W; Wong B; Chin JY; Lee M; Coulter C; Braund R
    N Z Med J; 2016 Oct; 129(1444):90-96. PubMed ID: 27806032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current state of biologic pharmacovigilance in the European Union: improvements are needed.
    Felix T; Jordan JB; Akers C; Patel B; Drago D
    Expert Opin Drug Saf; 2019 Mar; 18(3):231-240. PubMed ID: 30714424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the Methods to Obtain Paediatric Drug Safety Information: Spontaneous Reporting and Healthcare Databases, Active Surveillance Programmes, Systematic Reviews and Meta-analyses.
    Gentili M; Pozzi M; Peeters G; Radice S; Carnovale C
    Curr Clin Pharmacol; 2018; 13(1):28-39. PubMed ID: 29412117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden.
    Holm L; Ekman E; Jorsäter Blomgren K
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):335-343. PubMed ID: 28071845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Italian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system.
    Magro L; Arzenton E; Moretti U; Sottosanti L; Potenza S; Leone R
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):69-75. PubMed ID: 27875920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacoepidemiological characterization of drug-induced adverse reaction clusters towards understanding of their mechanisms.
    Mizutani S; Noro Y; Kotera M; Goto S
    Comput Biol Chem; 2014 Jun; 50():50-9. PubMed ID: 24534381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Editorial: adverse drug reactions].
    Taegtmeyer AB
    Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
    [No Abstract]   [Full Text] [Related]  

  • 38. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media.
    Ghosh R; Lewis D
    Expert Opin Drug Saf; 2015; 14(12):1845-53. PubMed ID: 26436834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.